Understanding Ozempic for Weight Loss: Dosing Guidelines and Insights

Last reviewed: June 21, 2026

Last updated: June 21, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has demonstrated an average weight loss of 15% body weight in clinical trials when combined with lifestyle modifications. Understanding how semaglutide dosing is structured helps patients set realistic expectations and recognize why gradual increases are essential for both safety and efficacy. PlexusDx provides access to compounded semaglutide from licensed 503A pharmacies, with transparent monthly pricing that remains flat regardless of dose progression.

How Semaglutide Dosing Works for Weight Loss

Semaglutide injections follow a titratable protocol designed to minimize gastrointestinal side effects while building tolerance. Most patients begin at a starting dose of 0.25 mg once weekly, then progress through escalation phases over several weeks or months. This gradual titration allows the body to adapt to the medication's effects on appetite regulation and blood sugar control, ultimately supporting sustained weight loss outcomes.

The progression typically moves from 0.25 mg to 0.5 mg, then to 1.0 mg, and potentially to 2.0 mg or higher, depending on individual response and clinical goals. Each dose increase is spaced weeks apart to allow tolerance to develop. Patients should not expect linear weight loss at each dose level; rather, the cumulative effect of consistent therapy—combined with reduced caloric intake—drives the weight reduction seen in clinical studies.

Clinical Evidence for Semaglutide Efficacy

Major randomized controlled trials, including the STEP program, show that semaglutide produces significantly greater weight loss than placebo or standard care. Participants on semaglutide lost between 9% and 16% of their baseline body weight over 68 weeks, depending on the dose studied. Beyond weight reduction, semaglutide also improved cardiovascular risk markers, including blood pressure and cholesterol levels, in trial populations.

The mechanism behind semaglutide's effectiveness involves binding to GLP-1 receptors in the brain and pancreas, which slows gastric emptying, increases feelings of fullness, and reduces hunger-driven eating behavior. This combination of reduced appetite and improved glucose handling creates a physiological environment favorable for weight loss, even when patients do not dramatically restrict calories. The effect compounds over time, meaning consistent adherence across multiple months yields more substantial results than sporadic use.

Why Your Dose May Change, but Your Price Won't

Many weight loss programs structure costs around dose levels, charging more as patients progress to higher strengths. PlexusDx operates differently—Compounded Semaglutide Injections are $189/mo month-to-month, or from $149/mo on the 6-month plan, and this monthly price remains flat regardless of whether a patient remains at 0.25 mg or escalates to 2.0 mg. This pricing model removes financial barriers to proper dose optimization and ensures patients pursue the dose their body needs, not the dose their wallet can afford.

Dose escalation in response to clinical progress is a normal part of semaglutide therapy. Some patients achieve significant results at moderate doses, while others benefit from higher doses for maximal appetite suppression. PlexusDx's flat-rate model aligns patient incentives with clinical outcomes—patients can safely increase their dose to the therapeutic level without worrying about unexpected bill increases. All medications are sourced from licensed 503A compounding pharmacies and are HSA/FSA eligible.

Personalized Dosing with Precision Peptide Genetic Testing

Individual variation in GLP-1 therapy response is partly driven by genetic differences in appetite-regulation pathways. The Precision Peptide Genetic Test offered by PlexusDx examines key variants in GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313), among others across 14 distinct pathways. These genetic insights help clinicians anticipate how a patient's body may respond to semaglutide and identify whether alternative or combination therapies might be beneficial.

By mapping 49 distinct peptides and generating 150+ genetic insights, PlexusDx enables truly personalized GLP-1 selection and dosing strategies. A patient with certain genetic predispositions may achieve excellent results at lower doses, while another may require higher therapeutic levels or a different compound altogether. The genetic test is available as $298, allowing patients to gather baseline clinical experience before investing in deeper genetic analysis.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

What dose of semaglutide should I start at for weight loss?

Most patients begin semaglutide therapy at 0.25 mg injected once weekly, regardless of their final target dose. This low starting point allows tolerance to develop and helps minimize nausea or other gastrointestinal effects. Your healthcare provider will assess your response after 4 weeks and determine whether to increase to the next dose level.

How long does it take to see weight loss results on semaglutide?

Clinical trial data shows meaningful weight loss typically becomes noticeable after 4-8 weeks of consistent therapy, with more substantial results appearing after 12-16 weeks. The STEP trials demonstrated that patients lost an average of 5-10% of body weight by week 16, with continued progression to 15% or more by week 68. Individual results vary based on adherence, diet quality, exercise, and genetic factors.

How much does PlexusDx compounded semaglutide cost each month?

PlexusDx Compounded Semaglutide Injections are $189/mo month-to-month, or from $149/mo on the 6-month plan—and this price remains the same whether you use 0.25 mg weekly or escalate to 2.0 mg weekly. No insurance is required, and the medication is HSA/FSA eligible. There is no membership fee, and PlexusDx serves all 50 states.

What are the most common side effects of semaglutide for weight loss?

Nausea, vomiting, diarrhea, and constipation are the most frequently reported side effects, particularly when starting or increasing doses. These symptoms typically diminish within days or weeks as the body adjusts. Serious side effects are rare but can include pancreatitis or severe dehydration; patients with a personal or family history of medullary thyroid cancer should not use semaglutide.

Can genetic testing help determine my ideal semaglutide dose?

Yes. PlexusDx's Precision Peptide Genetic Test examines variants in GIPR and FTO, and MC4R genes, among others, that influence appetite regulation and drug response. These insights can help your provider anticipate whether you may respond well at standard doses or may benefit from higher or lower starting points, or from alternative compounds like tirzepatide.

Related Reading

• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Weight Loss Drugs Like Ozempic
• Ozempic Weight Loss Before And After Pictures

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.